Loading...
•
Jun 30
Radnet Q2 2025 Earnings Report
RadNet achieved record quarterly revenue and adjusted EBITDA in Q2 2025, driven by strong growth in both Imaging Center and Digital Health segments.
Key Takeaways
RadNet reported Q2 2025 revenue of $498.2M, up 8.4% year-over-year, with net income of $14.45M and adjusted EPS of $0.31. Operating income reached $30.88M, supported by increased advanced imaging volumes and robust performance in the Digital Health segment. PET/CT volumes grew over 22% year-over-year, and the company raised its full-year revenue and EBITDA guidance.
Revenue reached a record $498.2M, up 8.4% from Q2 2024.
Digital Health segment revenue grew 30.9% to $20.7M.
PET/CT volumes increased 22.4% year-over-year.
Full-year 2025 revenue and EBITDA guidance were raised.
Radnet
Radnet
Radnet Revenue by Segment
Revenue by Segment
Imaging Center Revenue
CapyFin.comDigital Health Revenue
CapyFin.com Forward Guidance
RadNet increased its 2025 guidance ranges for revenue and adjusted EBITDA, reflecting strong demand, expansion of advanced imaging capacity, and growth in Digital Health.
Positive Outlook
- Raised full-year revenue and EBITDA guidance after strong Q2 results.
- Ongoing expansion with one new imaging center opened and nine more planned for 2025.
- Continued growth in advanced imaging, particularly PET/CT.
- Expansion of AI-powered breast cancer detection program.
- Implementation of remote scanning technology to address staffing challenges.
Challenges Ahead
- Increased operating expenses due to expansion initiatives.
- Continued staffing challenges in certain markets.
- Impact from non-capitalized R&D expenses for Digital Health products.
- Competitive pressures in routine imaging services.
- Dependency on reimbursement rates from payors.